Quantitative evaluation of non-enhanced IDH-mutant diffuse glioma using synthetic MRI provided better accuracy for differentiating astrocytoma from oligodendroglioma than did the T2-FLAIR mismatch sign. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).